Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT06778512

LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer

Led by The First Affiliated Hospital of Guangzhou Medical University · Updated on 2025-01-16

2500

Participants Needed

1

Research Sites

391 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will utilize tissue and peripheral blood samples for proteomics analysis and establish a longitudinal proteomics cohort at multiple critical treatment time points to explore the research value of proteomics in the diagnosis and treatment of lung cancer. The study includes key time points such as screening, postoperative efficacy prediction, and efficacy prediction after medication.

CONDITIONS

Official Title

LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent form
  • Male or female aged 18 to 75 years
  • Lung nodules confirmed by CT scan
  • Good cooperation for preoperative pulmonary function tests with complete reports
  • Preoperative chest single or dual phase CT scans without significant artefacts and complete imaging
  • Interval between preoperative pulmonary function and CT scans no longer than one month
Not Eligible

You will not qualify if you...

  • Poor cooperation for preoperative pulmonary function tests or missing reports
  • Preoperative chest CT scans with significant artefacts or missing images
  • Interval between preoperative pulmonary function and CT scans longer than one month
  • Severe respiratory disorders such as lung transplantation, pneumothorax, or giant bullae
  • Other severe functional impairments
  • Presence of obstructive lesions like airway or esophageal stenosis
  • Medication use before pulmonary function testing not following cessation guidelines
  • Pulmonary function report quality graded D to F

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

the First Affiliated of Guangzhou Medical University

Guangzhou, Guangdong, China, 510120

Actively Recruiting

Loading map...

Research Team

J

Jianxing He, Professor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here